Fulgent Genetics, Inc. (FLGT)
USD 18.74
(-3.6%)
USD 18.74
(-3.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 27 Million | 253.52 Million | 538.57 Million | 140.62 Million | 5.51 Million | -675 Thousand |
| Net Income | -167.82 Million | 141.92 Million | 506.23 Million | 214.31 Million | -411 Thousand | -5.6 Million |
| Depreciation & Amortization | 31.75 Million | 32.66 Million | 11 Million | 2.96 Million | 2.1 Million | 2.16 Million |
| Deferred income taxes | 11.46 Million | 831 Thousand | -7.84 Million | -1.39 Million | -21 Thousand | 36 Thousand |
| Stock-based compensation | 42.92 Million | 32.64 Million | 15.88 Million | 8.15 Million | 3.2 Million | 2.3 Million |
| Change in working capital | 2.84 Million | 2 Million | -2.67 Million | -91.45 Million | -915 Thousand | -1.24 Million |
| Other non-cash items | 105.84 Million | 43.45 Million | 15.96 Million | 8.04 Million | 1.54 Million | 1.67 Million |
| Investing Cash Flow | 38.89 Million | -261.31 Million | -546.54 Million | -326.43 Million | -29.04 Million | 950 Thousand |
| Investments in PPE | -22.2 Million | -18.77 Million | -23.84 Million | -36.51 Million | -1.31 Million | -2.83 Million |
| Acquisitions | 376 Thousand | -182.67 Million | -61.86 Million | -2.59 Million | 137 Thousand | 510 Thousand |
| Investment purchases | -491.91 Million | -432.98 Million | -730.49 Million | -324.35 Million | -52.07 Million | -24.18 Million |
| Sales/Maturities of investments | 552.64 Million | 372.71 Million | 269.59 Million | 37.01 Million | 24.35 Million | 27.96 Million |
| Other Investing Activities | 61.5 Million | 412 Thousand | 63 Thousand | 8000.00 | -137 Thousand | -510 Thousand |
| Financing Cash Flow | -47.78 Million | -77.14 Million | 85.39 Million | 261.25 Million | 28.77 Million | 15 Thousand |
| Debt repayment | -4.99 Million | -1.06 Million | -11 Thousand | -15.01 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -27.79 Million | -74.33 Million | -4.15 Million | -62 Thousand | -21 Thousand | - |
| Common Stock Issuance | 3000.00 | 31 Thousand | 89.56 Million | 246.19 Million | 28.75 Million | 15 Thousand |
| Other Financing Activities | -14.99 Million | -1.76 Million | -4.14 Million | 45.16 Million | 38 Thousand | 15 Thousand |
| Accounts receivables | 2.38 Million | 68.63 Million | 42.3 Million | -178.48 Million | -839 Thousand | -1.97 Million |
| Accounts payables | -6.89 Million | -25.33 Million | -12.2 Million | 22.61 Million | -329 Thousand | 102 Thousand |
| Inventory | - | - | - | - | - | -36.18 Million |
| Other working capital | 7.34 Million | -41.29 Million | -32.77 Million | 64.41 Million | 253 Thousand | 36.8 Million |
| Cash at beginning of period | 79.5 Million | 164.89 Million | 87.42 Million | 11.96 Million | 6.73 Million | 6.49 Million |
| Cash at end of period | 97.47 Million | 79.5 Million | 164.89 Million | 87.42 Million | 11.96 Million | 6.73 Million |
| Capital Expenditure | -22.2 Million | -18.77 Million | -23.84 Million | -36.51 Million | -1.31 Million | -2.83 Million |
| Effect of forex changes on cash | -149 Thousand | -453 Thousand | 34 Thousand | 20 Thousand | -17 Thousand | -44 Thousand |
| Net cash flow / Change in cash | 17.96 Million | -85.38 Million | 77.46 Million | 75.46 Million | 5.22 Million | 246 Thousand |
| Free Cash Flow | 4.79 Million | 234.74 Million | 514.73 Million | 104.11 Million | 4.19 Million | -3.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.71 Million | -13.46 Million | -128.14 Million | -167.82 Million | -13.46 Million | -11.59 Million |
| Depreciation & Amortization | 6.15 Million | 6.66 Million | 6.53 Million | 31.75 Million | 6.41 Million | 6.31 Million |
| Deferred income taxes | -457 Thousand | -557 Thousand | 502 Thousand | 11.46 Million | 19.1 Million | -3.21 Million |
| Stock-based compensation | 11.63 Million | 11.51 Million | 11.43 Million | 42.92 Million | 10.9 Million | 10.32 Million |
| Change in working capital | -2.58 Million | 4.9 Million | 10.23 Million | 2.84 Million | -11.17 Million | 8.57 Million |
| Other non-cash items | 23.22 Million | 21.8 Million | 114.38 Million | 105.84 Million | -1.54 Million | -668 Thousand |
| Investing Cash Flow | 7.3 Million | -47.18 Million | 24.27 Million | 38.89 Million | 20.07 Million | -1.09 Million |
| Investments in PPE | -12.94 Million | -4.05 Million | -3.1 Million | -22.2 Million | -4.92 Million | -12.14 Million |
| Acquisitions | 17 Thousand | 258 Thousand | -64 Thousand | 376 Thousand | 22 Thousand | 220 Thousand |
| Investment purchases | -63.08 Million | -195.74 Million | -148.31 Million | -491.91 Million | -93.06 Million | -106.61 Million |
| Sales/Maturities of investments | 83.31 Million | 152.35 Million | 175.75 Million | 552.64 Million | 118.04 Million | 117.43 Million |
| Other Investing Activities | 20.24 Million | 258 Thousand | 27.77 Million | 61.5 Million | 25 Million | 11.04 Million |
| Financing Cash Flow | -1.14 Million | -2.8 Million | -25.95 Million | -47.78 Million | -4.47 Million | -16.25 Million |
| Debt repayment | -602 Thousand | -900 Thousand | -10.59 Million | -4.99 Million | -15.12 Million | -231 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -544 Thousand | -225 Thousand | -23.97 Million | -27.79 Million | -2.71 Million | -232 Thousand |
| Common Stock Issuance | - | - | -3000.00 | 3000.00 | - | 3000.00 |
| Other Financing Activities | -544 Thousand | -1.68 Million | -12.57 Million | -14.99 Million | 13.37 Million | -15.79 Million |
| Accounts receivables | -2.87 Million | 1.48 Million | -5.2 Million | 2.38 Million | -12.06 Million | 10.32 Million |
| Accounts payables | 1.84 Million | -245 Thousand | 129 Thousand | -6.89 Million | -2.57 Million | -2.59 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.54 Million | 3.66 Million | 15.31 Million | 7.34 Million | 3.46 Million | 843 Thousand |
| Cash at beginning of period | 54.67 Million | 97.47 Million | 84.07 Million | 79.5 Million | 58.34 Million | 66.17 Million |
| Cash at end of period | 65.11 Million | 54.67 Million | 97.47 Million | 97.47 Million | 84.07 Million | 58.34 Million |
| Capital Expenditure | -12.94 Million | -4.05 Million | -3.1 Million | -22.2 Million | -4.92 Million | -12.14 Million |
| Effect of forex changes on cash | -9000.00 | -69 Thousand | 145 Thousand | -149 Thousand | -116 Thousand | -206 Thousand |
| Net cash flow / Change in cash | 10.43 Million | -42.79 Million | 13.39 Million | 17.96 Million | 25.72 Million | -7.82 Million |
| Free Cash Flow | -8.65 Million | 3.21 Million | 11.82 Million | 4.79 Million | 5.31 Million | -2.4 Million |
ZUGER
3555
2068
BHSC
SCGP-R
DIT